Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.730
+0.060 (1.28%)
Aug 14, 2026, 1:01 PM EDT - Market open
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $110.95 million as of August 14, 2026. Its market cap has increased by 7.00% in one year.
Market Cap
110.95M
Enterprise Value
67.77M
1-Year Change
7.00%
Ranking
Category
Stock Price
$4.73
ChartMarket Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $110.95M, an increase of 837.32%. That is a compound annual growth rate of 85.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 110.95M | -8.58% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genelux | 119.90M |
| Yarrow Bioscience | 119.76M |
| Seer, Inc. | 118.38M |
| Vivani Medical | 118.14M |
| Indaptus Therapeutics | 115.51M |
| Nautilus Biotechnology | 114.49M |
| enGene Therapeutics | 113.88M |
| Fractyl Health | 110.42M |